<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37001432</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9157</ISSN><JournalIssue CitedMedium="Internet"><Volume>136</Volume><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of autoimmunity</Title><ISOAbbreviation>J Autoimmun</ISOAbbreviation></Journal><ArticleTitle>Protein phosphatase 2A propels follicular T helper cell development in lupus.</ArticleTitle><Pagination><StartPage>103028</StartPage><MedlinePgn>103028</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaut.2023.103028</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0896-8411(23)00037-9</ELocationID><Abstract><AbstractText>Follicular helper T (Tfh) cells are important for generating humoral immune responses by helping B cells form germinal centers (GCs) and the production of high-affinity antibodies. However, aberrant Tfh cell expansion also contributes to the generation of self-reactive autoantibodies and promotes autoantibody-mediated autoimmune diseases such as systemic lupus erythematosus (SLE). Protein phosphatase 2A catalytic subunit alpha isoform (PP2A C&#x3b1;) expression levels are elevated in peripheral T cells of SLE patients and positively correlate with autoantibody titers and disease activity. Here, we demonstrate a critical role of PP2A in Tfh differentiation by using T cell restricted PP2A C&#x3b1; deficient mice. We observed impaired Tfh differentiation and GC response in two different classical Tfh induction models. Mechanistic studies revealed that downregulation of protein translation of the Tfh lineage transcription factor BCL6 in PP2A deficient T cells. Importantly, we found that PP2A deficiency by either gene knockout or chemical inhibition alleviated lupus severity in mice. Lastly, we confirmed a positive correlation between PP2A C&#x3b1; and BCL6 protein levels in human CD4<sup>+</sup> T cells from patients with SLE. In summary, our study revealed a critical role of PP2A in regulating Tfh cells and suggests it is a potential therapeutic target for lupus.</AbstractText><CopyrightInformation>Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Immunology, and Department of Rheumatology in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Xuexiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Immunology, and Department of Rheumatology in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi</LastName><ForeName>Zhexu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>International Institutes of Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang, 322000, China; Department of Immunology, Zhejiang University School of Medicine, Hangzhou, 310058, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Yadan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Immunology, and Department of Rheumatology in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manthiram</LastName><ForeName>Kalpana</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cell Signaling and Immunity Section, Laboratory of Immune System Biology (LISB), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mudd</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Pediatric Otolaryngology, Children's National Hospital, Washington, DC, USA; Division of Otolaryngology, Department of Surgery, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Kaixiang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Immunology, and Department of Rheumatology in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, PR China; Shanghai Immune Therapy Institute, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, 200127, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Immunology, Zhejiang University School of Medicine, Hangzhou, 310058, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwartzberg</LastName><ForeName>Pamela L</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Cell Signaling and Immunity Section, Laboratory of Immune System Biology (LISB), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Yongmei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Model Animals for Disease Study of the Ministry of Education, Model Animal Research Center, Nanjing University, Nanjing, 210061, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Linrong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Immunology, and Department of Rheumatology in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, PR China; Shanghai Immune Therapy Institute, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, 200127, China. Electronic address: lu_linrong@zju.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Qin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Immunology, and Department of Rheumatology in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, PR China; Cell Signaling and Immunity Section, Laboratory of Immune System Biology (LISB), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA. Electronic address: qin.xu@nih.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ZIA AI001345</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Autoimmun</MedlineTA><NlmUniqueID>8812164</NlmUniqueID><ISSNLinking>0896-8411</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.1.3.16</RegistryNumber><NameOfSubstance UI="D054648">Protein Phosphatase 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006377" MajorTopicYN="Y">T-Lymphocytes, Helper-Inducer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054648" MajorTopicYN="N">Protein Phosphatase 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PP2A</Keyword><Keyword MajorTopicYN="N">SLE</Keyword><Keyword MajorTopicYN="N">Tfh</Keyword><Keyword MajorTopicYN="N">mTOR</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>18</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37001432</ArticleId><ArticleId IdType="mid">NIHMS1887353</ArticleId><ArticleId IdType="pmc">PMC10327577</ArticleId><ArticleId IdType="doi">10.1016/j.jaut.2023.103028</ArticleId><ArticleId IdType="pii">S0896-8411(23)00037-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kerfoot SM, Yaari G, Patel JR, Johnson KL, Gonzalez DG, Kleinstein SH et al. Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone. Immunity, 2011;34:947&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3280079</ArticleId><ArticleId IdType="pubmed">21636295</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Ma W, Zhang T, Wu L, Qi H. Phenotypic Tfh development promoted by CXCR5-controlled re-localization and IL-6 from radiation-resistant cells. Protein &amp; cell, 2015;6:825&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4624673</ArticleId><ArticleId IdType="pubmed">26404031</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Hou S, Fang Q, Liu X, Liu X, Qi H. PD-1 Controls Follicular T Helper Cell Positioning and Function. Immunity, 2018;49:264&#x2013;74 e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6104813</ArticleId><ArticleId IdType="pubmed">30076099</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Xu H, Shih C, Wan Z, Ma X, Ma W. et al. T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction. Nature, 2015;517:214&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25317561</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert J ACP, DiToro Daniel, Yusuf Isharat, Eto Danelle,, Burton Barnett ALD, Craft Joe, Crotty Shane. Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell Differentiation. science, 2009;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2766560</ArticleId><ArticleId IdType="pubmed">19608860</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatzi K, Nance JP, Kroenke MA, Bothwell M, Haddad EK, Melnick A. et al. BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms. The Journal of experimental medicine, 2015;212:539&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4387288</ArticleId><ArticleId IdType="pubmed">25824819</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J, Crotty S. Bcl6-Mediated Transcriptional Regulation of Follicular Helper T cells (TFH). Trends Immunol, 2021;42:336&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8021443</ArticleId><ArticleId IdType="pubmed">33663954</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsiari CG, Kyttaris VC, Juang YT, Tsokos GC Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. The Journal of clinical investigation, 2005;115:3193&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1253625</ArticleId><ArticleId IdType="pubmed">16224536</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JY, Ho JH, Pasoto SG, Bunin V, Kim ST, Carrasco S. et al. Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis &amp; rheumatology, 2015;67:988&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4450082</ArticleId><ArticleId IdType="pubmed">25581113</ArticleId></ArticleIdList></Reference><Reference><Citation>Faliti CE, Gualtierotti R, Rottoli E, Gerosa M, Perruzza L, Romagnani A. et al. P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus. The Journal of experimental medicine, 2019;216:317&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6363434</ArticleId><ArticleId IdType="pubmed">30655308</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi W, Gupta S, Ricker E, Manni M, Jessberger R, Chinenov Y. et al. The mTORC1&#x2013;4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity. Nature communications, 2017;8:254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5557982</ArticleId><ArticleId IdType="pubmed">28811467</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuyama T, Li H, Comte D, Tsokos GC, Moulton VR Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity. The Journal of clinical investigation, 2019;129:5411&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6877308</ArticleId><ArticleId IdType="pubmed">31487268</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X, Song Y, Du P, Yang S, Cui H, Lu S. et al. Administration of a microRNA-21 inhibitor improves the lupus-like phenotype in MRL/lpr mice by repressing Tfh cell-mediated autoimmune responses. Int Immunopharmacol, 2022;106:108578.</Citation><ArticleIdList><ArticleId IdType="pubmed">35124415</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan X, Shen C, Zhang X, Wu L, Chen J, Ma B. et al. Toll-like receptor 7 agonist imiquimod prevents the progression of SLE in MRL/lpr mice via inhibiting the differentiation of T follicular helper cells. Int Immunopharmacol, 2020;80:106239.</Citation><ArticleIdList><ArticleId IdType="pubmed">32007709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruvolo PP The broken &#x201c;Off&#x201d; switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance. BBA clinical, 2016;6:87&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986044</ArticleId><ArticleId IdType="pubmed">27556014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Pham HT, Walter G. The formation and activity of PP2A holoenzymes do not depend on the isoform of the catalytic subunit. J Biol Chem, 2003;278:8617&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">12506124</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, Jin X, Zheng M, Rohila D, Fu G, Wen Z. et al. Phosphatase PP2A is essential for TH17 differentiation. Proc Natl Acad Sci U S A, 2019;116:982&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6338861</ArticleId><ArticleId IdType="pubmed">30593560</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolidis SA, Rodriguez-Rodriguez N, Suarez-Fueyo A, Dioufa N, Ozcan E, Crispin JC et al. Phosphatase PP2A is requisite for the function of regulatory T cells. Nature immunology, 2016;17:556&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4837024</ArticleId><ArticleId IdType="pubmed">26974206</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt T, Paust HJ, Krebs CF, Turner JE, Kaffke A, Bennstein SB et al. Function of the Th17/interleukin-17A immune response in murine lupus nephritis. Arthritis &amp; rheumatology, 2015;67:475&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">25385550</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Zhang X, Wei Y, Sun X, Chen Y, Deng J. et al. Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus. Nat Med, 2016;22:991&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">27500725</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasshoff H, Comduhr S, Monne LR, Muller A, Lamprecht P, Riemekasten G. et al. Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases. Front Immunol, 2021;12:648408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8047324</ArticleId><ArticleId IdType="pubmed">33868284</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma K, Li J, Wang X, Lin X, Du W, Yang X. et al. TLR4(+)CXCR4(+) plasma cells drive nephritis development in systemic lupus erythematosus. Ann Rheum Dis, 2018;77:1498&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">29925508</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM A unifying model for mTORC1-mediated regulation of mRNA translation. Nature, 2012;485:109&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3347774</ArticleId><ArticleId IdType="pubmed">22552098</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X, Xu Q, Pu C, Zhu K, Lu C, Jiang Y. et al. Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus. Cellular &amp; molecular immunology, 2021;18:1896&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8322088</ArticleId><ArticleId IdType="pubmed">32472023</ArticleId></ArticleIdList></Reference><Reference><Citation>Mingzhu Zheng DL, Zhao Zhishan, Shytikov Dmytro, Xu Qin, Jin Xuexiao, Liang Jingjing,, Jun Lou SW, Wang Lie, Hu Hu, Zhou Yiting, Gao Xiang, and Lu Linrong. Protein phosphatase 2A has an essential role in promoting thymocyte survival during selection. PNAS, 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6589683</ArticleId><ArticleId IdType="pubmed">31152132</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao J, Lv Z, Zhang P, Wang Y, Yuan M, Yu X. et al. AID assists DNMT1 to attenuate BCL6 expression through DNA methylation in diffuse large B-cell lymphoma cell lines. Neoplasia, 2020;22:142&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7021553</ArticleId><ArticleId IdType="pubmed">32062068</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu HR, Kim YJ, Lee HR KSHV vIRF4 enhances BCL6 transcription via downregulation of IRF4 expression. Biochem Biophys Res Commun, 2018;496:1128&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">29397940</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunahori K, Nagpal K, Hedrich CM, Mizui M, Fitzgerald LM, Tsokos GC The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/phosphorylated ERK/DNMT1 protein pathway in T-cells from controls and systemic lupus erythematosus patients. J Biol Chem, 2013;288:21936&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3724648</ArticleId><ArticleId IdType="pubmed">23775084</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao W, Spolski R, Li P, Du N, West EE, Ren M. et al. Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression. Proc Natl Acad Sci U S A, 2014;111:3508&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3948278</ArticleId><ArticleId IdType="pubmed">24550509</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M, Li D, Zhao Z, Shytikov D, Xu Q, Jin X. et al. Protein phosphatase 2A has an essential role in promoting thymocyte survival during selection. Proc Natl Acad Sci U S A, 2019;116:12422&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6589683</ArticleId><ArticleId IdType="pubmed">31152132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinnebusch AG The Scanning Mechanism of Eukaryotic Translation Initiation. Annual Review of Biochemistry, 2014;83:779&#x2013;812.</Citation><ArticleIdList><ArticleId IdType="pubmed">24499181</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SM, Yoon SY, Choi JE, Park JS, Choi JM, Nguyen T. et al. Activation of eukaryotic initiation factor-2 alpha-kinases in okadaic acid-treated neurons. Neuroscience, 2010;169:1831&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20600673</ArticleId></ArticleIdList></Reference><Reference><Citation>Roux PP, Topisirovic I. Regulation of mRNA translation by signaling pathways. Cold Spring Harbor perspectives in biology, 2012;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3536343</ArticleId><ArticleId IdType="pubmed">22888049</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian HP, Qiu TZ, Zhao J, Li LX, Guo J. Sphingomyelinase-induced ceramide production stimulate calcium-independent JNK and PP2A activation following cerebral ischemia. Brain Inj, 2009;23:1073&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">19891536</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmond RJ, Emery J, Okkenhaug K, Zamoyska R. MAPK, phosphatidylinositol 3-kinase, and mammalian target of rapamycin pathways converge at the level of ribosomal protein S6 phosphorylation to control metabolic signaling in CD8 T cells. J Immunol, 2009;183:7388&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">19917692</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Xu XJ, Zheng Mingzhu, Rohila Deepak, Fu Guotong, Wen Zhuoyu, Lou Jun,, Songquan RS, Wang Lie, HuHu, Gao Xiang, and Lu Linrong. Phosphatase PP2A is essential for TH17 differentiation. PNAS, 2019:982&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6338861</ArticleId><ArticleId IdType="pubmed">30593560</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong LI Y.-y. Z., SUN Ya-nan, Xi-yi HUANG, JIA Yong-feng, LI Duan. Induction of systemic lupus erythematosus syndrome in BALB/c mice by immunization with active chromatin. Acta Pharmacol Sin, 2004;25:807&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">15169636</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen Z, Xu L, Xu W, Xiong S. Retinoic Acid Receptor-Related Orphan Nuclear Receptor gammat Licenses the Differentiation and Function of a Unique Subset of Follicular Helper T Cells in Response to Immunogenic Self-DNA in Systemic Lupus Erythematosus. Arthritis &amp; rheumatology, 2021;73:1489&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pubmed">33559400</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazhar S, Taylor SE, Sangodkar J, Narla G. Targeting PP2A in cancer: Combination therapies. Biochim Biophys Acta Mol Cell Res, 2019;1866:51&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6436821</ArticleId><ArticleId IdType="pubmed">30401535</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MM, Kalim UU, Khan MH, Lahesmaa R. PP2A and Its Inhibitors in Helper T-Cell Differentiation and Autoimmunity. Front Immunol, 2021;12:786857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8766794</ArticleId><ArticleId IdType="pubmed">35069561</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Dong J, Deng L. Overview of Cantharidin and its Analogues. Curr Med Chem, 2018;25:2034&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">28413963</ArticleId></ArticleIdList></Reference><Reference><Citation>Honkanen RE Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A. FEBS Lett, 1993;330:283&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8397101</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez JJ, Candenas ML, Souto ML, Trujillo MM &amp; Norte M. Okadaic Acid, Useful Tool for Studying Cellular Processes. Curr Med Chem, 2002;9:229&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">11860357</ArticleId></ArticleIdList></Reference><Reference><Citation>Juang YT, Wang Y, Jiang G, Peng HB, Ergin S, Finnell M. et al. PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells. J Immunol, 2008;181:3658&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2662392</ArticleId><ArticleId IdType="pubmed">18714041</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmond RJ, Brownlie RJ, Meyuhas O, Zamoyska R. Mechanistic Target of Rapamycin Complex 1/S6 Kinase 1 Signals Influence T Cell Activation Independently of Ribosomal Protein S6 Phosphorylation. J Immunol, 2015;195:4615&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4635570</ArticleId><ArticleId IdType="pubmed">26453749</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi W, Gupta S, Ricker E, Manni M, Jessberger R, Chinenov Y. et al. The mTORC1&#x2013;4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity. Nature Communications, 2017;8:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5557982</ArticleId><ArticleId IdType="pubmed">28811467</ArticleId></ArticleIdList></Reference><Reference><Citation>D. e. a. Barth-Baus. S6 phosphorylation-independent pathways regulate translation of 5&#x2032;-terminal oligopyrimidine tract-containing mRNAs in differentiating hematopoietic cells. Nucleic Acids Res, 2002;30:1919&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113832</ArticleId><ArticleId IdType="pubmed">11972328</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H, Perl A. Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8-double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus. J Immunol, 2014;192:4134&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3995867</ArticleId><ArticleId IdType="pubmed">24683191</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichhorn PJ, Creyghton MP, Bernards R. Protein phosphatase 2A regulatory subunits and cancer. Biochimica et biophysica acta, 2009;1795:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">18588945</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>